Elicio Therapeutics, Inc.

Elicio Therapeutics, Inc.

Est. revenue
$5M–$10M
Total raised
$379M
Latest round
Post-IPO Equity
Employees
47

Funding & revenue at Elicio Therapeutics, Inc.

How well capitalized the business is — useful context before you scope a fractional engagement or negotiate a rate.

Estimated annual revenue

$5M–$10M

Modeled range, not company-reported

Total capital raised

$379M

9 known investors

Latest round

Post-IPO Equity · $15M

Jul 2026

Publicly traded

ELTX, ELICIOTHERAPEUTICS

IPO Jun 2023

Investors

Access BridgeGap VenturesAngionClal Biotechnology IndustriesEFung CapitalGKCCGastro-Intestinal Research FoundationLivzon Pharmaceutical GroupThynk CapitalTrend Investment Group

Growth signals

How fast Elicio Therapeutics, Inc. is adding people, roles, and audience.

Employees

47

Reported band 11-50

Open roles

1

0% year over year

LinkedIn followers

6.8K

+42.1% year over year

Headcount change

MoM
0%
0 people
QoQ
0%
0 people
6mo
+2.2%
+1 people
YoY
+11.9%
+5 people
2yr
+17.5%
+7 people

Team composition

Where Elicio Therapeutics, Inc. concentrates its people — a read on which function a fractional leader would plug into.

By function

  • Research1532%
  • Business Development613%
  • Legal49%
  • Operations49%
  • Accounting36%
  • Information Technology36%
  • Finance24%
  • Human Resources24%

By region

  • United States45
  • Greater Boston25
  • Massachusetts, United States22
  • Boston, MA12
  • California, United States8
  • Cambridge, MA6

Inside Elicio Therapeutics, Inc.

What the business focuses on, where it operates, and how employees rate it.

Categories

BiotechnologyHealth CareMedicalPharmaceuticalTherapeuticsBiotech & PharmaceuticalsPharmaceutical and biotechnology

Markets

PRIVATENASDAQ

Competitors

Companies in the same market as Elicio Therapeutics, Inc..

https://www.immunowake.com/http://www.immunomix.comhttp://verthermia.comhttp://www.lavatherapeutics.com/https://ose-immuno.comhttps://mendus.com/https://tactivatherapeutics.comhttp://www.oleandermedicaltechnologies.comhttp://www.bellicum.comhttp://www.eutilex.comhttp://www.ellodipharma.comhttp://climbbio.comhttp://www.Immunovative.comhttp://www.myelotherapeutics.comhttps://electra-therapeutics.com/http://www.elpiscience.com/

Elicio Therapeutics, Inc. in the news

Recent coverage picked up alongside the firmographic refresh.

Funding, revenue, headcount, and hiring figures are third-party estimates from public sources and are not confirmed by the company. Last refreshed October 14, 2026.

About this page

This company page is automatically generated based on publicly available job postings. Company information is sourced from publicly available data and may not be complete. If you represent Elicio Therapeutics, Inc., you can claim this page to manage and enhance it.